Login / Signup

Effect of belimumab treatment on antiphospholipid antibody levels: post-hoc analysis based on two randomised placebo-controlled trials in systemic lupus erythematosus.

Katerina ChatzidionysiouEvangelia SamoliPetros P SfikakisMaria G G Tektonidou
Published in: Annals of the rheumatic diseases (2019)
Keyphrases
  • placebo controlled
  • systemic lupus erythematosus
  • double blind
  • clinical trial
  • study protocol
  • open label
  • phase ii
  • phase iii
  • squamous cell carcinoma
  • combination therapy
  • radiation therapy